
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Coffee peel extracts ameliorate non-alcoholic fatty liver disease via a fibroblast growth factor 21–adiponectin signaling pathway
Zekai Fan, Chong Wang, Ting Yang, et al.
Food & Function (2022) Vol. 13, Iss. 13, pp. 7251-7259
Closed Access | Times Cited: 9
Zekai Fan, Chong Wang, Ting Yang, et al.
Food & Function (2022) Vol. 13, Iss. 13, pp. 7251-7259
Closed Access | Times Cited: 9
Showing 9 citing articles:
Preventive and therapeutic effects of natural products and herbal extracts on nonalcoholic fatty liver disease /nonalcoholic steatohepatitis
Yiming Cao, Xiaoxue Fang, Mingyang Sun, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 9, pp. 3867-3897
Open Access | Times Cited: 11
Yiming Cao, Xiaoxue Fang, Mingyang Sun, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 9, pp. 3867-3897
Open Access | Times Cited: 11
Transcriptomic analysis reveals the mechanisms underlying the differential effects of caffeine, theophylline, and theobromine in regulating hepatic fat accumulation
Jinya Dong, Xiaocui Du, Ruijuan Yang, et al.
Food & Function (2025)
Closed Access
Jinya Dong, Xiaocui Du, Ruijuan Yang, et al.
Food & Function (2025)
Closed Access
Coffee peel polyphenols ameliorate nonalcoholic fatty liver disease by modulating cannabinoid receptor type‐1‐ceramide axis
Zekai Fan, Yanfang Chen, Wei Han, et al.
Phytotherapy Research (2025)
Closed Access
Zekai Fan, Yanfang Chen, Wei Han, et al.
Phytotherapy Research (2025)
Closed Access
p-Synephrine ameliorates non-alcoholic fatty liver disease by regulating liver-adipose axis via AMPK/NF-kappa B pathway
Wei‐Feng Cai, Qi-Cong Chen, Qian Ni, et al.
Journal of Ethnopharmacology (2025), pp. 119890-119890
Closed Access
Wei‐Feng Cai, Qi-Cong Chen, Qian Ni, et al.
Journal of Ethnopharmacology (2025), pp. 119890-119890
Closed Access
Dual-Stimuli-Responsive Gut Microbiota-Targeting Nitidine Chloride-CS/PT-NPs Improved Metabolic Status in NAFLD
Jianmei Lu, Yongzhu Zeng, Huashuai Zhong, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2409-2428
Open Access | Times Cited: 3
Jianmei Lu, Yongzhu Zeng, Huashuai Zhong, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2409-2428
Open Access | Times Cited: 3
NOD-like receptors in the pathogenesis of metabolic (dysfunction)-associated fatty liver disease: Therapeutic agents targeting NOD-like receptors
Shaghayegh Khanmohammadi, Bruno Ramos‐Molina, Mohammad Shafi Kuchay
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 7, pp. 102788-102788
Closed Access | Times Cited: 8
Shaghayegh Khanmohammadi, Bruno Ramos‐Molina, Mohammad Shafi Kuchay
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 7, pp. 102788-102788
Closed Access | Times Cited: 8
Network Pharmacology to Reveal the Molecular Mechanisms of Rutaceous Plant-derived Limonin Ameliorating Non-alcoholic Steatohepatitis
Wei Wang, Li Yang, Minjie Hu, et al.
Critical Reviews in Immunology (2023) Vol. 43, Iss. 5, pp. 11-23
Closed Access | Times Cited: 3
Wei Wang, Li Yang, Minjie Hu, et al.
Critical Reviews in Immunology (2023) Vol. 43, Iss. 5, pp. 11-23
Closed Access | Times Cited: 3
A herb mixture to ameliorate non-alcoholic fatty liver in rats fed a high-fat diet
Sang Keun Ha, Jin-Ah Lee, Donghwan Kim, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e18889-e18889
Open Access | Times Cited: 2
Sang Keun Ha, Jin-Ah Lee, Donghwan Kim, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e18889-e18889
Open Access | Times Cited: 2
P-Synephrine Ameliorates Non-Alcoholic Fatty Liver Disease by Regulating Liver-Adipose Axis Via Ampk/Nf-Kappa B Pathway
Wei‐Feng Cai, Qi-Cong Chen, Qian Ni, et al.
(2024)
Closed Access
Wei‐Feng Cai, Qi-Cong Chen, Qian Ni, et al.
(2024)
Closed Access
The effect and application of adiponectin in hepatic fibrosis
Libin Chen, Wenjing Yang, Rongrong Dong, et al.
Gastroenterology report (2023) Vol. 12
Open Access | Times Cited: 1
Libin Chen, Wenjing Yang, Rongrong Dong, et al.
Gastroenterology report (2023) Vol. 12
Open Access | Times Cited: 1